SCHEMBL26239641

SCHEMBL26239641

CCCCCCc1ccc(C(=O)OC)cc1CCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 4/20 0.50
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
CYP4F2 P78329 2/20 0.46
CYP4A11 Q02928 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 2/20 0.45
TSHR P16473 2/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
ALOX5 P09917 1/20 0.45
TYR P14679 1/20 0.45
ALOX15 P16050 1/20 0.45
HTT P42858 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35610 0.97 MGLL (0.48) MGLLALDH1A1MEN1KMT2ACYP4F2
SCHEMBL5072219 0.88 KDM4E (0.53) MGLLALDH1A1MEN1KMT2ACYP4F2
SCHEMBL7064779 0.88 KDM4E (0.53) MGLLALDH1A1MEN1KMT2ACYP4F2
SCHEMBL15173906 0.88 MGLL (0.54) MGLLALDH1A1MEN1KMT2ACYP4F2
SCHEMBL1935282 0.88 KDM4E (0.53) MGLLALDH1A1MEN1KMT2ACYP4F2
SCHEMBL3517818 0.88 KDM4E (0.53) MGLLALDH1A1MEN1KMT2ACYP4F2
SCHEMBL15173835 0.87 MGLL (0.60) MGLLMAPTALOX5
SCHEMBL15174008 0.87 MGLL (0.47) MGLLALDH1A1MEN1KMT2ACYP4F2
SCHEMBL8085884 0.87 MGLL (0.60) MGLLMAPTALOX5
SCHEMBL10680744 0.86 ALDH1A1 (0.56) MGLLALDH1A1MEN1KMT2ACYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024098361-A1 ARTIFICIAL NUCLEIC ACID MOLECULE 斯微(上海)生物科技股份有限公司 2024-05-16 WO disclosed
US-20230263742-A1 A LIPID Stemirna Therapeutics Co., Ltd. (CN) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263742-A1 A LIPID CETP, PLIN1, AUP1 MGLL 43/4885ALDH1A1 1643/4885MEN1 1924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.